Eldepryl is used for treating the symptoms of Parkinson's disease in adults. This medication works by helping to increase the amount of a certain chemical in the brain (dopamine). A dopamine deficiency is thought to be responsible for many of the symptoms of Parkinson's disease. Off-label Eldepryl uses include the treatment of Alzheimer's disease, depression, and schizophrenia.
Eldepryl® (selegiline hydrochloride) is a Parkinson's disease medication. It belongs to a group of medications known as monoamine oxidase inhibitors (MAOIs). It is only approved for use in combination with carbidopa-levodopa medications (such as Sinemet®, Sinemet® CR, or Parcopa®). Eldepryl is specifically designed for people who are experiencing a reduced response to their carbidopa-levodopa therapy.
Parkinson's disease results from the loss of neurons in a region of the brain that controls movement. This creates a shortage of the neurotransmitter (brain-signaling chemical) known as dopamine, causing movement problems that are characteristic of Parkinson's disease. The exact cause of Parkinson's disease is not currently known.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click